[
Skip to content
]
Contact Us
|
Login
|
Accessibility
|
Low graphics
|
Text Size:
A
A
A
Monday, 21 May 2012
HOME
PARKINSON'S
DECISION AID
AWARENESS
CAMPAIGN
REWRITE
TOMORROW
COPING
STRATEGIES
MED INFO
PATIENT
GUIDE
SITE MAP
Search our Site
Search our site
Advanced search
(0)
Add page to PDF basket
Tweet
Share
You are here
»
Home
»
Publications
»
EPDA Plus
»
Download issues
»
EPDA Plus Issue 12
«
Download issues
EPDA Plus Issue 12
EUROPEAN PARKINSON'S DISEASE ASSOCIATION
.
EPDA Plus Issue 12 - Winter 2010
Click on image to download
Contents
Ali awarded Irish PD honour
Muhammad Ali, one of the greatest sportsmen the world has ever seen – and the most famous person with Parkinson’s – has become the Honorary President of the Parkinson’s Association of Ireland (PAI) following revelations that he is of Irish descent.
Researchers win £5m to find a Parkinson's cure
The Oxford Parkinson’s Disease Consortium, a team of researchers at the University of Oxford, has won the UK PDS’s Monument Discovery Award – and with it funding of £5m over five years for groundbreaking new research into finding a cure for Parkinson’s.
Cara doubles her expectations
A seasoned runner risked injury and exhaustion to raise more than £4,000 – more than twice the amount she was expecting – for various charities, including Parkinson’s, when she ran three major races within four weeks.
Exercise programmes ‘protect against Parkinson’s’, says study
Claims that long-term exercise protects against the loss of dopamine-producing cells and energy-producing mitochondria in neurons has been supported by new USbased evidence.
Gardners’ question time
Working with pesticides significantly increases the risk of developing neurological conditions, new study reveals
Cure Parkinson’s Trust launches Self-Assessment Tool
The Cure Parkinson’s Trust (UK) has launched a new resource to help people with Parkinson’s (PWPs) take more control over their condition.
NAB to honour Michael J Fox for charity work
Michael J Fox, actor, author and advocate for increased funding for Parkinson’s research, will receive the National Association of Broadcasters’ (NAB) distinguished service award at this year’s show
Personal Care at Home Bill introduced to UK Parliament
A Bill designed to help individuals with the highest care needs remain independent for longer has been introduced to the UK parliament.
EU president backs disability demands at Freedom Drive
The president of the European parliament has committed to fight for the rights of people with disabilities – including those with Parkinson’s – after 440 people from 21 countries met in Strasbourg late last year for the Freedom Drive.
Rasagiline ‘can help’ fatigue in early Parkinson’s
Rasagiline appears to be an effective treatment for symptoms of fatigue in people with early Parkinson’s, according to a recent study.
Ropinirole ‘effective’ at reducing nocturnal symptoms in late PD
Nocturnal symptoms in patients with advanced Parkinson’s not optimally controlled with levodopa may be reduced by once daily treatment with prolonged release ropinirole. This is according to results from a recent Efficacy and Safety Evaluation in Parkinson’s disease (EASEPD) Adjunct study.
Cholesterol drug boost
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson’s from progressing further, new research has revealed.
IMI announcements
The Innovative Medicines Initiative (IMI) – the public-private partnership between the European Commission (EU) and the European pharmaceutical industry – announced in September the topics of research of its second call for proposals from research consortia that aims to accelerate the discovery and development of new medicines in the field of cancer, inflammatory and infectious disease.
MSD Supply shortage
Merck Sharp & Dohme (MSD) has announced that, starting in late 2009, there will be a shortage in the availability of Sinemet (carbidopalevodopa) and Sinemet CR (carbidopalevodopa controlled release).
Danish firm starts trial
Danish biopharma company NeuroSearch A/S has initiated a clinical study of its ACR325 candidate drug for the treatment of dyskinesias in Parkinson’s.
Counter attack
The facts surrounding the growth in availability of counterfeit medicines is both frightening and staggering. Illegal online pharmacies are proliferating rapidly, yet the European public remains largely ignorant of the issue. As a result, argues EAASM Chair Jim Thomson, these problems need to be tackled head-on and the fakers need to be dealt with.
The perfect Blend
There is currently a terrifying void between the huge number of people living with neurological disorders and those that are qualified to nurse them. As a result, the European Association of Neuroscience Nurses has created the NeuroBlendTM framework in an attempt to turn the precarious situation around. Paul van Keeken and Christine Eberhardie report.
2010 set to be ‘year of action’ for EPDA
The EPDA’s annual general assembly, held in Budapest at the beginning of October, was hailed as the best for many years, with the programme packed full of exciting initiatives due to be carried out in 2010.
EPDA annual conference highlights the benefits of working together
The EPDA’s annual conference in Budapest, Hungary, held in early October, centred on working together, sharing experiences and promoting a positive outlook.
Clicking into high gear
A unique partnership between the EPDA and two pharmaceuticals companies has culminated in the launch of www.myPDinfo.com, an exciting new online resource for people with Parkinson’s. Dominic Graham reports on what can be achieved when patient organisations and industry work together.
Huge gong in EPDA’s sights
Life with Parkinson’s campaign shortlisted for prestigious European award.
An art-warming exhibition
Art and Parkinson’s was the theme of an exhibition organised by Parkinson Luxembourg (PL) in Luxembourg City in mid-October.
A humbling experience
Message from new EPDA President Knut-Johan Onarheim.
School’s IN for the summer
The first Parkinson’s disease summerschool was held in Turkey last July and has proved an outstanding success, combining teamwork, research and boundless raw enthusiasm. The initiative’s founder Paul de Roos talks to Dominic Graham about his hopes for the project and what it could mean for Parkinson’s in the future.
Speculating to accumulate
In a few short years, the internet has become the fastest, most prolific and influential medium in modern society – and with its bandwagon showing no signs of slowing, the EPDA is getting on board with the launch of its own YouTube channel. Chiu Man takes us on a journey through the past to a hopeful future of global sharing.
Journey inwards
At medical congresses and patient forums across Europe, a new band of UCB-sponsored Parkinson’s advocates are introducing audiences to their experiences of living with the disease. By describing their journeys, the group, consisting of people with Parkinson’s and their carers, are showing others how they are learning to live and adapt to their condition.
A date to remember
World Parkinson’s Disease Day is soon to mark its thirteenth year in April, which means a time for celebration for Parkinson’s associations around the world. Dominic Graham trawels the archives and looks back at some truly unique World Day occasions.